Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360919 · ClinicalTrials.gov registry record · Early Phase 1
Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
A Early Phase 1 study, sponsored by Physicians Committee for Responsible Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT00360919 is a Early Phase 1 study that has completed, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 28 participants.
The verdict
NCT00360919, a Early Phase 1 study, has completed, sponsored by Physicians Committee for Responsible Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This purpose of this study is to perform a pilot investigation to determine if opioid peptides such as casomorphin can be detected in human plasma after cheese ingestion.
Interventions
- BEHAVIORAL cheese ingestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360919
The ClinicalTrials.gov registry entry for NCT00360919 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Physicians Committee for Responsible Medicine, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cheese ingestion is the first listed.
NCT00360919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360919 about?
NCT00360919 is a clinical study titled "Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion". This purpose of this study is to perform a pilot investigation to determine if opioid peptides such as casomorphin can be detected in human plasma after cheese ingestion.
What is the current status of trial NCT00360919?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2006-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00360919?
The interventions under investigation include: cheese ingestion (BEHAVIORAL).
Who is sponsoring clinical trial NCT00360919?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.